Movatterモバイル変換


[0]ホーム

URL:


Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log inShow account info
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
pubmed logo
Advanced Clipboard
User Guide

Full text links

Nature Publishing Group full text link Nature Publishing Group Free PMC article
Full text links

Actions

.2020 Aug 14;11(1):4081.
doi: 10.1038/s41467-020-17972-1.

A single dose of an adenovirus-vectored vaccine provides protection against SARS-CoV-2 challenge

Affiliations

A single dose of an adenovirus-vectored vaccine provides protection against SARS-CoV-2 challenge

Shipo Wu et al. Nat Commun..

Abstract

The unprecedented coronavirus disease 2019 (COVID-19) epidemic has created a worldwide public health emergency, and there is an urgent need to develop an effective vaccine to control this severe infectious disease. Here, we find that a single vaccination with a replication-defective human type 5 adenovirus encoding the SARS-CoV-2 spike protein (Ad5-nCoV) protect mice completely against mouse-adapted SARS-CoV-2 infection in the upper and lower respiratory tracts. Additionally, a single vaccination with Ad5-nCoV protects ferrets from wild-type SARS-CoV-2 infection in the upper respiratory tract. This study suggests that the mucosal vaccination may provide a desirable protective efficacy and this delivery mode is worth further investigation in human clinical trials.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1. Adenovirus-based vaccine design and immunogenicity in mice.
a Schematic of SARS-CoV-2 S immunogens.b Western blot of transgene expression from (1) Soriginal, (2) SPtPA add Smature, (3) SPoriginal add Soptimized, (4) SPtPA add Soptimized, and (5) an empty plasmid transfected in HEK293 cells. BALB/c mice (n = 10 per group) received a single immunization with different doses of Ad5-nCoV or Ad5 vector by the IM or IN route.ch, Humoral immune responses were assessed at weeks 0, 2, 4, 6 and 8 following vaccination by S-specific ELISAc,f, SARS-CoV-2 NAb titration (MN50)d,g and SARS-CoV-2 PNAb titratione,h withn = 10 biologically independent animals per group. Data represent the individual titre of each animal and the connecting lines reflect the geometric means of the titres.i,j, Cellular immune responses were assessed at day 14 following vaccination in the 5 × 108 VP dose groups by intracellular cytokine staining assays withn = 10 biologically independent animals per group. Data are presented as mean ± s.e.m. Statistical significance was determined by Kruskal–Wallis ANOVA with Dunn’s multiple comparisons tests. S = spike protein, SP = signal peptide, tPA = tissue plasminogen activator. Dotted line = the limit of detection. Source data are provided as a Source Data file.
Fig. 2
Fig. 2. Protective efficacy of Ad5-nCoV in mice.
BALB/c mice (n = 10 biologically independent animals per group) received a single immunization with different doses of Ad5-nCoV or Ad5 vector by the IM or IN route, and seven of ten mice were challenged at week 10 with 103.6 PFU of mouse-adapted SARS-CoV-2 virus HRB26M in a volume of 50 μL by the IN route. Tissue live virus numbersa and tissue viral loadsb were detected at 3 dpi (n = 4 biologically independent animals per group) and 5 dpi (n = 3 biologically independent animals per group) in the lungs and turbinates, respectively. Black bars reflect geometric means; 3 dpi = red circles; 5 dpi = blue squares; dotted line = the limit of detection. Source data are provided as a Source Data file.
Fig. 3
Fig. 3. Immunogenicity and protective efficacy of Ad5-nCoV in ferrets.
Ferrets (n = 6 biologically independent animals per group) received a single immunization by the IM route or two simultaneous doses by the IN and oral routes with 5 × 1010 VP per dose of Ad5-nCoV or received a sham vaccine. Humoral immune responses were assessed at week 4 following vaccination by S-specific ELISA (a) and NAb titration (PRNT90) (b).c Cellular immune response was assessed by IFNγ ELISpot assays. Live virus numbers (d) and viral load (e) of SARS-CoV-2 in nasal washes obtained from ferrets after challenge. Bar at the geometric mean, and connecting lines reflect geometric means; statistical significance was determined by Kruskal–Wallis ANOVA with Dunn’s multiple comparisons tests; IN and oral inoculation animals = red circles; IM injection animals = blue squares; control animals = brown triangles; dotted line = the limit of detection. Source data are provided as a Source Data file.
See this image and copyright information in PMC

References

    1. WHO. Draft landscape of COVID-19 candidate vaccines–15 July 2020.https://www.who.int/publications/m/item/draft-landscape-of-covid-19-cand.... Accessed 19 July 2020.
    1. Gao, Q. et al. Rapid development of an inactivated vaccine candidate for SARS-CoV-2.Science, 10.1126/science.abc1932 (2020). - PMC - PubMed
    1. van Doremalen, N. et al. ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques.Nature, 10.1038/s41586-020-2608-y (2020). - PubMed
    1. Yu, J. et al. DNA vaccine protection against SARS-CoV-2 in rhesus macaques.Science, 10.1126/science.abc6284 (2020). - PMC - PubMed
    1. Zhu F, et al. Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial. Lancet. 2015;385:2272–2279. doi: 10.1016/S0140-6736(15)60553-0. - DOI - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

Full text links
Nature Publishing Group full text link Nature Publishing Group Free PMC article
Cite
Send To

NCBI Literature Resources

MeSHPMCBookshelfDisclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.


[8]ページ先頭

©2009-2026 Movatter.jp